Shields Matthew
EVP, Global Operations
Shields Matthew has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Jun 22, 2026.
On the most recent filing, Shields Matthew is listed as EVP, Global Operations at TEVA PHARMACEUTICAL INDUSTRIES LTD. Inside the rolling window, Shields Matthew reported no open-market purchases and 3 open-market sales totaling $1.4M in TEVA. The largest disclosed transaction in the window is a sale of 17,295 TEVA shares on Mar 5, 2026, worth $548K.
Companies traded
Other insiders at TEVA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.4M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Shields Matthew made?
Shields Matthew has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company since 2026.
Which companies does Shields Matthew trade?
Shields Matthew has filed SEC Form 4 disclosures for 1 company, including TEVA.
When was Shields Matthew's most recent SEC Form 4 filing?
Shields Matthew's most recent SEC Form 4 filing on Tracefour is dated Jun 22, 2026.
What is Shields Matthew's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Shields Matthew is listed as EVP, Global Operations.
What is Shields Matthew's total buy and sell value in the current window?
Inside the rolling retention window, Shields Matthew bought $0 and sold $1.4M based on SEC Form 4 filings.
What was Shields Matthew's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 17,295 TEVA shares on 2026-03-05, worth $548K, per SEC Form 4 filings.